ZAI LAB LTD0000006
Research ZAI LAB LTD0000006 (1ZLB) on Bullrun: market cap EUR 2.47B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1ZLB
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 2.47B
- Financial periodQ2 2026
- RevenueUSD 106.31M
- Net income-USD 50.83M
- Free cash flow-USD 64.87M
- Gross margin54.7%
Valuation Snapshot
latest market cap is EUR 2.47B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 460.16M | -USD 175.54M | -USD 164.21M | 58.5% | n/a | USD 679.57M | USD 224.26M | USD 715.50M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 2.47B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About ZAI LAB LTD0000006
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ZAI LAB LTD0000006's market cap?
ZAI LAB LTD0000006's market capitalization is EUR 2.47B.
What does ZAI LAB LTD0000006 do?
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.